CAPRISA
 | A major contributor to this article appears to have a close connection with its subject. (July 2017) |
| Purpose | AIDS research |
|---|---|
| Location | |
Director | Salim Abdool Karim |
| Website | http://www.caprisa.org/ |
CAPRISA ("Centre for the AIDS Programme of Research in South Africa") is the name of an AIDS research center based in Durban, South Africa.
History[]
CAPRISA was established in 2002 under the National Institutes of Health program called (CIPRA). Five partner institutions participated in the founding: University of KwaZulu-Natal, University of Cape Town, University of Western Cape, National Institute of Communicable Diseases, and Columbia University in New York. UNAIDS recognizes CAPRISA with the designation of "Collaborating Centre for HIV Prevention Research."[1]
CAPRISA's mission is to promote HIV prevention and research its epidemiology.[1]
CAPRISA 004[]
CAPRISA 004 is the name of a clinical trial testing a microbicide which was experimentally shown to be effective in reducing women's risk of contracting HIV.[2]
References[]
- ^ a b "Founding of CAPRISA". CAPRISA. Archived from the original on 19 November 2011. Retrieved 23 January 2011.
- ^ Celia W. Dugger (19 July 2010). "African Studies Give Women Hope in H.I.V. Fight". The New York Times. Retrieved 23 January 2011.
External links[]
- Clinical trial organizations
- HIV/AIDS in South Africa
- Medical and health organisations based in South Africa